
A Total of USD 12.7 Million Investment in New Diagnostics and Drug Development for NTDs and Malaria to Partners Including the Ohio State University, PATH, GSK and Others
Global Health Innovative Technology Fund (GHIT Fund)
Education
Global Health Innovative Technology Fund (GHIT Fund)
Assembly
Frost & Sullivan
ISX Financial EU PLC